viper crowd

Hear ye! Hear ye! If you’ve got an awesome project you want to show off to the community at the largest DIY festival on Earth, you only have a few more days to get your application in. The Call for Makers originally was due to close last Sunday, but folks asked for a little extra time, and we’ve extended it to Sunday, March 2, 2014 at midnight PST, but this is the last call.


Maker Faire Bay Area is the Faire that started it all and this year we’re in our 9th year. Last year’s Maker Faire Bay Area featured 900+ maker exhibits and hosted 120,000 attendees representing 47 states and 36 countries. If you’re a maker, this is the place to be! Don’t delay — apply today!


There are a number of different types of maker applications:

  • Maker Exhibit – an all-weekend exhibit to demo your project(s) (includes Commercial Makers)

  • Performer – a scheduled performance, usually on a stage, set lengths vary
  • Presenter – a scheduled 10, 20 or 45 minute presentation, usually on a stage
  • Sponsor – established companies or commercial entities
  • Startup Sponsor – startup companies: <5 yrs in business, <10 employees, etc. Details in form.We particularly encourage exhibits that are interactive and that highlight the process of making things.


Here are just some of the topics that we’re looking for:

  • Student projects

  • Robotics
  • Homegrown drones
  • Arduino projects
  • Raspberry Pi
  • Space projects
  • Food makers (not concessionaires, more info below)
  • Conductive materials projects
  • Kit makers
  • Interactive art projects
  • 3D printers and CNC mills
  • Textile arts and crafts
  • E-textiles
  • Home energy monitoring
  • Rockets and R/C toys
  • Sustainability & green tech
  • Radios, vintage computers and game systems
  • Electronics
  • Electric vehicles
  • Science, biology/biotech, and chemistry projects
  • Puppets, kites, and other whimsical creations
  • Bicycles
  • Large-scale art
  • Shelter (tents, domes, etc.)
  • Music performances and participation
  • Unusual tools or machines
  • How to fix things or take them apart


You never know what maker-made wonders you’ll see at Maker Faire Bay Area, and that’s the beauty of it. You’re sure to leave inspired!


Also, this year the Power Racing Series is back! Participating teams from all over the country strip down and build up kids’ toy cars of the Power Wheels persuasion and race them on a specially designed track for hundreds of cheering fans. Rally your team and register to race!


Here’s a video of the Power Racing Series in effect:

Can’t participate as a maker at Maker Faire Bay Area, but want to attend? Discounted, early-bird tickets are available until March 17. Pick up your tickets today!

Goli Mohammadi

Goli Mohammadi

I’m a word nerd who loves to geek out on how emerging technology affects the lexicon. I was an editor on the first 40 volumes of MAKE, and I love shining light on the incredible makers in our community. In particular, covering art is my passion — after all, art is the first thing most of us ever made. When not fawning over perfect word choices, I can be found on the nearest mountain, looking for untouched powder fields and ideal alpine lakes.

Contact me at [email protected] or via @snowgoli.

  • haoyuan2014

    PCI-32765 and Bortezomib for B cell proliferation and tumor cell lines to study the effect and mechanism of apoptosis

    This study aimed to investigate the Btk inhibitor PCI-32765 and the proteasome inhibitor bortezomib for Raji, Ramos cell proliferation, apoptosis and its mechanism. After PCI-32765 and bortezomib monotherapy and combination therapy treatment Raji and Ramos cells, proliferation and apoptosis were using CCK-8 method and flow cytometry cells, Western blot assay Btk, NF-κB, c-IAP1, Bcl- xL, caspase-3 and other proteins. The results showed that: ①PCI-32765 (0.5,1.0,2.0,3.0,4.0,5.0,6.0μmol / L) and bortezomib (10,20,30,40,50,60,80 nmol / L) treated Raji and Ramos cells 48 h, can inhibit cell proliferation inhibition rate showed a dose-dependent, and the two drugs have a synergistic effect; ②PCI-32765 (2.0μmol / L), bortezomib (20 nmol / L) monotherapy and combination therapy to deal with different Raji and Ramos cells time (8,12,24,36,48,72 h), can inhibit cell viability in a time-dependent inhibition rate, and the two drugs have a synergistic effect; ③PCI-32765 (2μmol / L) and bortezomib (20 nmol / L) monotherapy and combination therapy treatment Raji and Ramos cells 48 h, could promote apoptosis of Raji and Ramos cells. Raji cell experiments, the control group, PCI-32765 and bortezomib monotherapy group, the apoptosis rate of the combined treatment group were 10.34 ± 0.53%, 24.26 ± 0.91%, 43.66 ± 1.08% and 74.06 ± 0.72%, in each group there were significant differences (P <0.05) between; Ramos cell experiments, the control group, PCI-32765 and bortezomib monotherapy group, the apoptosis rate combined treatment group was 15.16 ± 1.49%, 71.36 ± 0.82%, respectively, 75.32 ± 2.36% and 84.30 ± 0.91%, statistically significant (P <0.05) between the groups; ④PCI-32765 and bortezomib monotherapy treatment Raji, after Ramos cells, expression levels of intracellular Btk, NFκB, Bcl-xl and cIAP1 of lower than the control group, increased expression levels of Caspase-3, the latter two drugs, the enhanced role. Conclusion: PCI-32765 and bortezomib synergistically inhibit the proliferation of Raji and Ramos cells and promote apoptosis, the mechanism may be related to inhibition of Btk, NFκB activity, down Bcl-xl and c-IAP1 and other anti-apoptotic protein, while raising Caspase -3 expression of apoptosis proteins play a role.

    Medchemexpress Can provide the above product,its website: